Generic Name
Ertugliflozin and MetforminPacks Price
- Tab 2.5/500mg: Pack Size 2x7's: Rs.196
- Tab 2.5/1000mg: Pack Size 2x7's: Rs.224
- Tab 7.5/500mg: Pack Size 2x7's: Rs.294
- Tab 7.5/1000mg: Pack Size 2x7's: Rs.322
Ertuvia-M
Therapeutic Group
Blood Glucose Lowering Drugs, Excluding InsulinIndication Dosage
Ertugliflozin and Metformin is a combination medication designed to treat type 2 diabetes mellitus. Ertugliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that works by promoting the excretion of glucose in the urine, thereby lowering blood sugar levels. Metformin, on the other hand, is a biguanide that improves insulin sensitivity and reduces glucose production in the liver. This combination offers a dual mechanism of action to help control hyperglycemia in patients with type 2 diabetes. Ertugliflozin and Metformin are typically prescribed as an adjunct to diet and exercise when monotherapy with metformin or ertugliflozin alone is insufficient.
Dosage:
2.5mg Ertugliflozin/ 500mg Metformin twice daily; increase the dose as required. Max: 7.5, 5mg Ertugliflozin/ 1000mg Metformin.
Content
- Tab 2.5mg/ 500mg: Ertugliflozin and Metformin
- Tab 2.5mg/ 1000mg: Ertugliflozin and Metformin
- Tab 7.5mg/ 500mg: Ertugliflozin and Metformin
- Tab 7.5mg/ 1000mg: Ertugliflozin and Metformin
Pregnancy
Contraindicated in Pregnancy
Stability
- Sodium-glucose cotransporter-2 (SGLT2) inhibitor
- Biguanide
Contra Indications
- Type 1 Diabetes Mellitus, Severe Renal Impairment, end-stage Renal Disease, or Dialysis, Pancreatitis, Ketoacidosis, Hepatic Impairment.
Precautions
- Type 1 Diabetes Mellitus, Severe Renal Impairment, end-stage Renal Disease, or Dialysis, Pancreatitis, Ketoacidosis, Hepatic Impairment.
Lactation
- Contraindicated or Not Recommended
Side Effects
- Headache
- Abdominal Discomfort
- Diarrhoea
- Flatulence
- Nausea
- Vomiting
- Genital Mycotic Infection
Available Brands
Author
Shahid Arif